Top Markets
Coin of the day
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
शेयरों में रैंक #2339
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
शेयर मूल्य
$43.48
मार्केट कैप
$8.97B
बदलाव (1 दिन)
0.37%
बदलाव (1 वर्ष)
192.01%
देश
US
व्यापार Immunovant, Inc. (IMVT)

श्रेणी

Immunovant, Inc. (IMVT) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $42.52 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $9.88 (2019-06-01 को)
Immunovant, Inc. के स्टॉक मूल्य का इतिहास 2019 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$553.77 42.38%
US
$1.02K 50.70%
NL
$157.85 522.66%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH